T. Steinmetz

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)

Gϋnter von Minckwitz, Gϋnter von Minckwitz, Sibylle Loibl et al. · Annals of Oncology · 2014 · 140 citations

Medicine, Oncology, Pharmacology +15

Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia

T. Steinmetz, B. Tschechne, Olof Harlin et al. · Annals of Oncology · 2012 · 112 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Immunophenotyping of low‐grade B‐cell lymphoma in blood and bone marrow: poor correlation between immunophenotype and cytological/histological classification

Martin Schwonzen, Christoph Pohl, T. Steinmetz et al. · British Journal of Haematology · 1993 · 39 citations

Medicine, Hematology, Pathology +17

The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP

Fiona Streckmann, Maryam Balke, Helmar C. Lehmann et al. · BMC Cancer · 2018 · 38 citations · Full text

Medicine, Oncology, Rehabilitation Medicine +16

Phase I study of 24-hour continuous intravenous infusion of recombinant human tumor necrosis factor.

T. Steinmetz, M. Schaadt, R. Gähl et al. · PubMed · 1988 · 33 citations

Pharmacy, Pharmacokinetics, Pharmacology +11